Surgery Partners, Inc.
SGRY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,114 | $2,743 | $2,539 | $2,225 |
| % Growth | 13.5% | 8% | 14.1% | – |
| Cost of Goods Sold | $2,369 | $2,096 | $1,964 | $1,734 |
| Gross Profit | $746 | $648 | $575 | $491 |
| % Margin | 23.9% | 23.6% | 22.6% | 22.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $139 | $121 | $102 | $104 |
| SG&A Expenses | $139 | $121 | $102 | $104 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $258 | $199 | $128 | $85 |
| Operating Expenses | $397 | $320 | $230 | $189 |
| Operating Income | $349 | $328 | $345 | $302 |
| % Margin | 11.2% | 12% | 13.6% | 13.6% |
| Other Income/Exp. Net | -$202 | -$193 | -$235 | -$221 |
| Pre-Tax Income | $147 | $135 | $110 | $81 |
| Tax Expense | $135 | -$0 | $23 | $11 |
| Net Income | -$168 | -$12 | -$55 | -$71 |
| % Margin | -5.4% | -0.4% | -2.2% | -3.2% |
| EPS | -1.33 | -0.095 | -0.59 | -1.12 |
| % Growth | -1,304.4% | 83.9% | 47.3% | – |
| EPS Diluted | -1.33 | -0.095 | -0.59 | -1.12 |
| Weighted Avg Shares Out | 126 | 126 | 92 | 72 |
| Weighted Avg Shares Out Dil | 126 | 126 | 92 | 72 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $202 | $193 | $235 | $221 |
| Depreciation & Amortization | $153 | $118 | $115 | $99 |
| EBITDA | $501 | $446 | $460 | $401 |
| % Margin | 16.1% | 16.3% | 18.1% | 18% |